Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biodetection

    Dial-a-Threat Rapid Assay Generation Program Could Bypass Reliance on Cold-Chain Supply

    By Global Biodefense StaffOctober 8, 2021
    Suited up in protective gear, a first, personnel holding a droplet with sample of unknown biological agent leans over to place it into testing area
    Photo: Kelly White
    Share
    Facebook LinkedIn Reddit Email

    The DaT Program aims to develop a highly adaptive, all-encompassing biothreat detection modality that minimizes reliance on supply chain constrictions.

    The Dial-a-Threat (DaT) project at the U.S. Army Combat Capabilities Development Command – Chemical and Biological Center (DEVCOM-CBC) is harnessing novel synthetic-biology approaches to develop gene circuits that rapidly detect infectious diseases and biothreats.

    A cornerstone feature of the DaT program is the ability to reduce reliance on traditional cold-chain supply lines by using freeze-dried reagents. The assays also utilizes cellular extracts, reagents which can be quickly synthesized and scaled, making it a “leaner” logistical biotechnology for austere or resource-limited environments.

    These assays have comparable sensitivity and specificity to molecular assays, such as polymerase chain reaction (PCR), and the ease of use of a lateral flow immunoassay (LFI) to determine the presence or absence of a target of interest.

    The Dial-A-Threat module envisioned by the Chemical Biological Center researchers uses an interlocked design for various modules to generate sample-to-answer in the form of a colorimetric readout. Credit: DEVCOM-CBC

    The project shows promise to rapidly scale up assay production. A preliminary proof of concept demonstrated the ability to generate assay designs in as little as a day, builds in weeks, and the capacity to produce and test detection assays against new targets in months. Given this promise of shortened timelines, DaT used Coronavirus Aid, Relief, and Economic Security (CARES) Act funding to quickly pivot and begin development on a SARS-CoV-2 assay and to help accelerate overall development of DaT technology.

    The DaT program is part of the investment portfolio of the Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Department in its role as the Joint Science and Technology Office (JSTO) for Chemical and Biological Defense as it aims to develop novel, high-fidelity biodetection technologies that are simple to use, deliver results in under 30 minutes, and are stable for use in austere environments.

    READ ALSO:

    On-demand biomanufacturing of protective conjugate vaccines Science Advances

    Enzyme-Assisted Nucleic Acid Detection for Infectious Disease Diagnostics: Moving toward the Point-of-Care ACS Sensors

    Defense Threat Reduction Agency ECBC Editor Pick Innovation Rapid Diagnostics Supply Chain
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleInterplanetary Biosecurity: How Not to Contaminate Mars with Earth-Based Microbes
    Next Article USDA Pandemic Response and Safety Grants for Farmers Markets, Food Producers

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.